Genetic ancestry, skin reflectance and pigmentation genotypes in association with serum vitamin D metabolite balance
暂无分享,去创建一个
M. Shriver | J. Barnholtz-Sloan | T. Hartman | V. Chinchilli | V. Canfield | K. Cheng | T. Frudakis | Robin Taylor Wilson | L. Demers | G. Grove | Alanna N. Roff | Jonathan J Douds | Gang Chen | Tracey Fortugno | P. Dai | Sheila Ongeri Nikiforova
[1] J. Gallagher,et al. Relationship between vitamin D, parathyroid hormone, and bone health. , 2011, The Journal of clinical endocrinology and metabolism.
[2] V. Vaccarino,et al. Heritability and seasonal variability of vitamin D concentrations in male twins. , 2010, The American journal of clinical nutrition.
[3] E. Kilpatrick,et al. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. , 2010, Clinical chemistry.
[4] M. Galsky,et al. Docetaxel-based combination therapy for castration-resistant prostate cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] B. Boyan,et al. 24R,25-Dihydroxyvitamin D3, lysophosphatidic acid, and p53: A signaling axis in the inhibition of phosphate-induced chondrocyte apoptosis , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[6] Scott M. Williams,et al. Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[7] L. Declercq,et al. Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin. , 2010, Journal of dermatological science.
[8] R. Millikan,et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. , 2010, Carcinogenesis.
[9] Ryan E. Forster,et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[10] B. Boyan,et al. 24R,25-Dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1α,25(OH)2D3 in hypertrophic cells , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[11] M. V. Schiaffino. Signaling pathways in melanosome biogenesis and pathology. , 2010, The international journal of biochemistry & cell biology.
[12] H. Morris,et al. The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[13] H. Leffers,et al. Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[14] R. St-Arnaud. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24 , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[15] F. Lang,et al. Regulation of calcium signaling in dendritic cells by 1,25‐dihydroxyvitamin D3 , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] J. Simpson,et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. , 2010, JAMA.
[17] William Wheeler,et al. Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.
[18] Shosuke Ito,et al. Predicting Phenotype from Genotype: Normal Pigmentation * , 2010, Journal of forensic sciences.
[19] K. Dietrich,et al. Glucocorticoid therapy and risk of bladder cancer , 2009, British Journal of Cancer.
[20] Chong-K. Kim,et al. Pharmacokinetics of oral calcitriol in healthy human based on the analysis with an enzyme immunoassay. , 2009, Pharmacological research.
[21] Kenneth R Feingold,et al. pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. , 2009, The Journal of investigative dermatology.
[22] Christoph Lange,et al. Recovering unused information in genome-wide association studies: the benefit of analyzing SNPs out of Hardy–Weinberg equilibrium , 2009, European Journal of Human Genetics.
[23] M. Khaled,et al. αMSH and Cyclic AMP Elevating Agents Control Melanosome pH through a Protein Kinase A-independent Mechanism , 2009, The Journal of Biological Chemistry.
[24] Wei Chen,et al. Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P loci. , 2009, The Journal of investigative dermatology.
[25] Elizabeth A Yetley,et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.
[26] H. Wulf,et al. Sunbed Radiation Provokes Cutaneous Vitamin D Synthesis in Humans—A Randomized Controlled Trial , 2008, Photochemistry and photobiology.
[27] J. Woo,et al. Very high rates of vitamin D insufficiency in women of child-bearing age living in Beijing and Hong Kong , 2008, British Journal of Nutrition.
[28] L. Carbone,et al. 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. , 2008, Metabolism: clinical and experimental.
[29] Mark Shriver,et al. A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications , 2008, Human mutation.
[30] B. Hammock,et al. Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry , 2008, Analytical and bioanalytical chemistry.
[31] J. Rockell,et al. Association between quantitative measures of skin color and plasma 25-hydroxyvitamin D , 2008, Osteoporosis International.
[32] G. Novelli,et al. Haplotypes in SLC24A5 Gene as Ancestry Informative Markers in Different Populations , 2008, Current genomics.
[33] G. Costin,et al. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. , 2008, Current drug targets.
[34] Jill S Barnholtz-Sloan,et al. Ancestry Estimation and Correction for Population Stratification in Molecular Epidemiologic Association Studies , 2008, Cancer Epidemiology Biomarkers & Prevention.
[35] T. Dadd,et al. SLC24A5 Encodes a trans-Golgi Network Protein with Potassium-dependent Sodium-Calcium Exchange Activity That Regulates Human Epidermal Melanogenesis* , 2008, Journal of Biological Chemistry.
[36] D. Cox,et al. A genomewide association study of skin pigmentation in a South Asian population. , 2007, American journal of human genetics.
[37] David Moher,et al. Effectiveness and safety of vitamin D in relation to bone health. , 2007, Evidence report/technology assessment.
[38] M. Holick,et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. , 2007, Archives of biochemistry and biophysics.
[39] P. Schnetkamp,et al. Structure–Function Relationships of the NCKX2 Na+/Ca2+‐K+ Exchanger , 2007, Annals of the New York Academy of Sciences.
[40] R. Kittles,et al. Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. , 2006, Molecular biology and evolution.
[41] B. Henderson,et al. Racial/Ethnic Differences in Postmenopausal Endogenous Hormones: The Multiethnic Cohort Study , 2006, Cancer Epidemiology Biomarkers & Prevention.
[42] R. Wallace,et al. Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. , 2006, American journal of public health.
[43] B. Genge,et al. Effects of 24R,25‐ and 1α,25‐dihydroxyvitamin D3 on mineralizing growth plate chondrocytes , 2006, Journal of cellular biochemistry.
[44] B. Segmuller,et al. Degradation chemistry of a Vitamin D analogue (ecalcidene) investigated by HPLC-MS, HPLC-NMR and chemical derivatization. , 2006, Journal of pharmaceutical and biomedical analysis.
[45] J. Manson,et al. Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.
[46] H. Boshuizen,et al. Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[47] Keith C. Cheng,et al. SLC24A5, a Putative Cation Exchanger, Affects Pigmentation in Zebrafish and Humans , 2005, Science.
[48] S. Hankinson,et al. Racial Differences in Premenopausal Endogenous Hormones , 2005, Cancer Epidemiology Biomarkers & Prevention.
[49] Glenville Jones,et al. Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.
[50] B. Fuller,et al. The relationship between Na(+)/H(+) exchanger expression and tyrosinase activity in human melanocytes. , 2004, Experimental cell research.
[51] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[52] Scott M. Williams,et al. A high-density admixture map for disease gene discovery in african americans. , 2004, American journal of human genetics.
[53] M. Cogswell,et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.
[54] P. Vestergaard,et al. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized‐controlled study on the effects of loop‐ and thiazide‐diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women , 2001, European journal of clinical investigation.
[55] S. Cummings,et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. , 2001, The Journal of clinical endocrinology and metabolism.
[56] B. Fuller,et al. Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. , 2001, Experimental cell research.
[57] P. Clarys,et al. Skin color measurements: comparison between three instruments: the Chromameter®, the DermaSpectrometer® and the Mexameter® , 2000, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[58] M. Brilliant,et al. Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. , 2000, The Journal of investigative dermatology.
[59] F. Glorieux,et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. , 2000, Endocrinology.
[60] S. Fukushima,et al. Chemopreventive effect of 24R,25-dihydroxyvitamin D(3) in N, N'-dimethylhydrazine-induced rat colon carcinogenesis. , 2000, Carcinogenesis.
[61] B. Dawson-Hughes,et al. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. , 1998, The American journal of clinical nutrition.
[62] F. Muskiet,et al. Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose , 1998, British Journal of Nutrition.
[63] F. Glorieux,et al. The 25‐Hydroxyvitamin D 1‐Alpha‐Hydroxylase Gene Maps to the Pseudovitamin D‐Deficiency Rickets (PDDR) Disease Locus , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[64] A. Norman,et al. Three‐Fold Induction of Renal 25‐Hydroxyvitamin D3‐24‐Hydroxylase Activity and Increased Serum 24,25‐Dihydroxyvitamin D3 Levels Are Correlated with the Healing Process After Chick Tibial Fracture , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[65] P. Elias,et al. Skin type, but neither race nor gender, influence epidermal permeability barrier function. , 1995, Archives of dermatology.
[66] R. Marks,et al. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. , 1995, Archives of dermatology.
[67] H. DeLuca,et al. Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[68] R. Marcus,et al. 90300684 Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women , 1991 .
[69] J. Zerwekh,et al. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism. , 1989, The Journal of clinical endocrinology and metabolism.
[70] L. Lin,et al. A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.
[71] T. Fitzpatrick. The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of dermatology.
[72] B. Specker,et al. Serial ultraviolet B exposure and serum 25 hydroxyvitamin D response in young adult American blacks and whites: no racial differences. , 1988, Journal of the American College of Nutrition.
[73] R. Globus,et al. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. , 1986, The Journal of clinical investigation.
[74] A. Norman,et al. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. , 1985, Mineral and electrolyte metabolism.
[75] C. Ainley,et al. Biliary excretion of radioactivity after intravenous administration of 3H-1,25-dihydroxyvitamin D3 in man. , 1985, Digestive diseases and sciences.
[76] M. Holick,et al. Aging decreases the capacity of human skin to produce vitamin D3. , 1985, The Journal of clinical investigation.
[77] R. Turner,et al. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. , 1984, The Journal of clinical investigation.
[78] B. Hollis,et al. Defective photoproduction of cholecalciferol in normal and uremic humans. , 1984, The Journal of nutrition.
[79] T. Kuroki,et al. Regulation of Terminal Differentiation of Cultured Mouse Epidermal Cells by lα,25-Dihydroxyvitamin D3 , 1983 .
[80] A. Norman,et al. Evidence for circadian rhythms in the serum levels of the vitamin D‐dependent calcium‐binding protein and in the activity of the 25‐hydroxyvitamin D3‐1‐α‐hydroxylase in the chick , 1982, FEBS letters.
[81] J. Adams,et al. INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.
[82] M. Holick,et al. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. , 1981, The Journal of investigative dermatology.
[83] J. Bourgoignie,et al. Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs. , 1980, The Journal of clinical investigation.
[84] A. Norman,et al. Studies on the metabolism of calciferol. XIV: Evidence of a circadian rhythm in the activity of the 25-hydroxyvitamin D3-1-hydroxylase. , 1979, Biochemical and biophysical research communications.
[85] M. Haussler,et al. Influence of estrogen on renal vitamin D hydroxylases and serum 1alpha,25-(OH)2D3 in chicks. , 1978, The American journal of physiology.
[86] H. DeLuca,et al. 1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. , 1973, The Journal of biological chemistry.
[87] I. Macintyre. Vitamin D metabolism. , 1973, The New England journal of medicine.
[88] B. Hollis. Detection of Vitamin D and Its Major Metabolites , 2011 .
[89] Christine L. Taylor,et al. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium , 2011 .
[90] M. Holick,et al. Photobiology of Vitamin D , 2010 .
[91] G. Cairano,et al. Effect of the administration of 1,25-dihydroxyvitamin D3 on serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis , 2006, Calcified Tissue International.
[92] D. Bikle. CHAPTER 35 – Vitamin D: Role in Skin and Hair , 2005 .
[93] M. Itoh,et al. Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in a normal Japanese population , 2004, Journal of Bone and Mineral Metabolism.
[94] M. Holick,et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.
[95] Z. Varghese,et al. Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. , 1992, Nephron.
[96] J. Kanis,et al. Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man. , 1978, Advances in experimental medicine and biology.
[97] M. Peacock,et al. Proceedings: Inhibitory effect of 24,25-dihydroxycholecalciferol on parathyroid hormone secretion in the goat. , 1975, The Journal of endocrinology.
[98] E. Mawer,et al. The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. , 1971, Clinical science.